Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement
- PMID: 35608574
- DOI: 10.1001/jama.2022.7013
Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons.
Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults.
Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma.
Evidence assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed.
Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).
Comment in
-
Screening for Glaucoma.JAMA. 2022 May 24;327(20):1961-1962. doi: 10.1001/jama.2022.6400. JAMA. 2022. PMID: 35608599 No abstract available.
Summary for patients in
-
Screening for Primary Open-Angle Glaucoma.JAMA. 2022 May 24;327(20):2030. doi: 10.1001/jama.2022.7531. JAMA. 2022. PMID: 35608579 No abstract available.
Similar articles
-
Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement.Ann Intern Med. 2013 Oct 1;159(7):484-9. doi: 10.7326/0003-4819-159-6-201309170-00686. Ann Intern Med. 2013. PMID: 24325017
-
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
-
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Jun 21;327(23):2326-2333. doi: 10.1001/jama.2022.8970. JAMA. 2022. PMID: 35727271 Review.
-
Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Jun 7;327(21):2123-2128. doi: 10.1001/jama.2022.7015. JAMA. 2022. PMID: 35608838
-
Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Oct 18;328(15):1534-1542. doi: 10.1001/jama.2022.16946. JAMA. 2022. PMID: 36219440
Cited by
-
Computational modelling of scleral photocrosslinking: from rat to minipig to human.J R Soc Interface. 2024 Jul;21(216):20240111. doi: 10.1098/rsif.2024.0111. Epub 2024 Jul 31. J R Soc Interface. 2024. PMID: 39081249 Free PMC article.
-
Diagnosing glaucoma in primary eye care and the role of Artificial Intelligence applications for reducing the prevalence of undetected glaucoma in Australia.Eye (Lond). 2024 Aug;38(11):2003-2013. doi: 10.1038/s41433-024-03026-z. Epub 2024 Mar 21. Eye (Lond). 2024. PMID: 38514852 Free PMC article. Review.
-
Advancements in Glaucoma Diagnosis: The Role of AI in Medical Imaging.Diagnostics (Basel). 2024 Mar 1;14(5):530. doi: 10.3390/diagnostics14050530. Diagnostics (Basel). 2024. PMID: 38473002 Free PMC article. Review.
-
Identifying, Understanding, and Addressing Disparities in Glaucoma Care in the United States.Transl Vis Sci Technol. 2023 Oct 3;12(10):18. doi: 10.1167/tvst.12.10.18. Transl Vis Sci Technol. 2023. PMID: 37889504 Free PMC article.
-
Use of artificial intelligence in forecasting glaucoma progression.Taiwan J Ophthalmol. 2023 May 23;13(2):168-183. doi: 10.4103/tjo.TJO-D-23-00022. eCollection 2023 Apr-Jun. Taiwan J Ophthalmol. 2023. PMID: 37484617 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
